Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Down 19.4% in November

Viemed Healthcare, Inc. (NASDAQ:VMD) saw a significant decrease in short interest in November. As of November 15th, there was short interest totalling 291,200 shares, a decrease of 19.4% from the October 31st total of 361,200 shares. Based on an average daily volume of 166,700 shares, the days-to-cover ratio is presently 1.7 days. Currently, 0.9% of the shares of the company are sold short.

Viemed Healthcare Trading Up 1.3 %

Shares of VMD stock opened at $8.67 on Friday. The stock has a 50-day simple moving average of $8.61 and a 200 day simple moving average of $7.61. The stock has a market capitalization of $337.61 million, a P/E ratio of 32.11 and a beta of 1.43. Viemed Healthcare has a fifty-two week low of $6.21 and a fifty-two week high of $10.44. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The company had revenue of $58.00 million during the quarter.

Insider Transactions at Viemed Healthcare

In other news, Director Nitin Kaushal sold 5,995 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total value of $51,437.10. Following the completion of the transaction, the director now directly owns 126,843 shares in the company, valued at $1,088,312.94. This trade represents a 4.51 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Randy E. Dobbs sold 36,261 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the sale, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 72,256 shares of company stock valued at $674,739. 20.00% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. National Bank of Canada FI boosted its position in shares of Viemed Healthcare by 91.2% in the 3rd quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after purchasing an additional 1,596 shares during the period. Evernest Financial Advisors LLC acquired a new position in shares of Viemed Healthcare in the second quarter worth about $66,000. Perkins Coie Trust Co purchased a new position in shares of Viemed Healthcare in the third quarter worth approximately $73,000. Price T Rowe Associates Inc. MD acquired a new stake in shares of Viemed Healthcare during the first quarter valued at approximately $97,000. Finally, PDT Partners LLC purchased a new stake in shares of Viemed Healthcare in the 3rd quarter valued at approximately $78,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.